HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Breakthrough trichosporonosis in patients with acute myeloid leukemia receiving micafungin.

AuthorsTomoaki Akagi, Kohei Yamaguti, Tizuko Kawamura, Toshihiko Nakumura, Komei Kubo, Hiromitu Takemori
JournalLeukemia & lymphoma (Leuk Lymphoma) Vol. 47 Issue 6 Pg. 1182-3 (Jun 2006) ISSN: 1042-8194 [Print] United States
PMID16840220 (Publication Type: Case Reports, Letter)
Chemical References
  • Antifungal Agents
  • Echinocandins
  • Lipopeptides
  • Lipoproteins
  • Peptides, Cyclic
  • Micafungin
Topics
  • Aged
  • Antifungal Agents (adverse effects, therapeutic use)
  • Diagnosis, Differential
  • Echinocandins
  • Fatal Outcome
  • Female
  • Humans
  • Leukemia, Myeloid, Acute (complications, drug therapy)
  • Lipopeptides
  • Lipoproteins (adverse effects, therapeutic use)
  • Male
  • Micafungin
  • Mycoses (complications, etiology)
  • Neutrophils (cytology)
  • Peptides, Cyclic (adverse effects, therapeutic use)
  • Treatment Outcome
  • Trichosporon (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: